Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (560)	11/19/1997 4:25:00 PM
From: Ryan Weisman	Read Replies (1) \| Respond to of 1894

Frank, I think it's all the "smoke and mirrors" of this field that is really scaring new investors away. Nobody knows what's what. It will take time for ACMI to gain moment. I'm thinking this quarters numbers are key. If they show another 400% increase in revenues and hint towards earnings for 1998, they could light a flame under what I think is a powder keg. But again, it takes time, and only time will tell. RYAN

To: Frank Buck who wrote (560)	11/19/1997 6:00:00 PM
From: Cisco	Read Replies (2) \| Respond to of 1894

Frank, The heat has been turned up for awhile! Chroma Vision (CVSN) is not the only one in trouble with allergations and lawsuits. Looks to me like NeoPath (NPTH), Neuromedical (NSIX), and Cytyc (CYTC) all are in the fight: fool.yahoo.com If AutoCyte (ACYT) keeps making those claims like you cited earlier today, they too may soon be in the fight. AccuMed (ACMI) may be the only player with clean hands. Of course they haven't said anything to get them into trouble, have they? Cisco BTW: When using the Fixed Font setting you have to hit the return key were you want each line to end. The fixed font setting doesn't automatically wrap long lines.